He has more than 25 years of experience in orthopedic and neurosurgery sales and 10 years of experience in non-invasive bone growth stimulation. Mr. Butler will help the company grow its sales channel and ink new distribution partnerships.
Theragen is the developer of ActaStim, a spinal fusion bone growth stimulator.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
